Bill Gates’ is about to mint millionaires (again) with Stargate.

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

MLTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.02%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $24,287,059.52

MoonLake Immunotherapeutics Insider Trading History Chart

MoonLake Immunotherapeutics Share Price & Price History

^$54.32

▲ +2.46 (4.74%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

MoonLake Immunotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/4/2024	Simon Sturge	Director	Sell	171,000	$53.72	$9,186,120.00	171,980
2/29/2024	Da Silva Jorge Santos	CEO	Sell	4,740	$55.89	$264,918.60	2,982,814
2/27/2024	Da Silva Jorge Santos	CEO	Sell	62,810	$55.00	$3,454,550.00	3,043,619
2/27/2024	Kristian Reich	Insider	Sell	29,431	$55.00	$1,618,705.00	70,071
2/20/2024	Da Silva Jorge Santos	CEO	Sell	20,000	$57.44	$1,148,800.00	3,107,554
2/20/2024	Kristian Reich	Insider	Sell	10,000	$57.43	$574,300.00	100,071
2/16/2024	Kristian Reich	Insider	Sell	10,000	$60.15	$601,500.00	110,071
2/15/2024	Da Silva Jorge Santos	CEO	Sell	20,000	$60.18	$1,203,600.00	3,147,554
2/14/2024	Kristian Reich	Insider	Sell	10,000	$62.43	$624,300.00	130,071
12/19/2023	Matthias Bodenstedt	CFO	Sell	94,736	$59.22	$5,610,265.92	526,167
10/4/2023	Bihua Chen	Major Shareholder	Buy	67,814	$57.32	$3,887,098.48	8,435,312
10/2/2023	Bihua Chen	Major Shareholder	Buy	74,911	$57.37	$4,297,644.07	8,217,011
6/30/2023	Bihua Chen	Major Shareholder	Buy	800,000	$50.00	$40,000,000.00	4,927,100
6/26/2023	Bihua Chen	Major Shareholder	Buy	450,000	$45.63	$20,533,500.00	4,127,100
3/20/2023	Bihua Chen	Major Shareholder	Buy	588,589	$19.71	$11,601,089.19	3,438,589

Financial Prophecy

From Porter & Company | Ad

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for MoonLake Immunotherapeutics (NASDAQ:MLTX)

93.85% of MoonLake Immunotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

MoonLake Immunotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	5,641	$0.28M	0.0%	+1,269.2%	0.009%
11/15/2024	Barclays PLC	5,641	$0.28M	0.0%	+1,269.2%	0.009%
11/15/2024	Y Intercept Hong Kong Ltd	20,325	$1.03M	0.1%	+55.4%	0.032%
11/15/2024	Wellington Management Group LLP	192,058	$9.68M	0.0%	-48.5%	0.301%
11/15/2024	State Street Corp	87,637	$4.42M	0.0%	+96.2%	0.137%
11/15/2024	Parkman Healthcare Partners LLC	102,813	$5.18M	0.7%	+1.6%	0.161%
11/15/2024	HighVista Strategies LLC	43,541	$2.20M	0.8%	+3.1%	0.068%
11/15/2024	Holocene Advisors LP	1,585,167	$79.92M	0.3%	-2.5%	2.481%
11/15/2024	Erste Asset Management GmbH	15,000	$0.74M	0.0%	N/A	0.023%
11/14/2024	Fred Alger Management LLC	666,574	$33.61M	0.2%	+1.1%	1.043%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	35,814	$1.81M	0.0%	+96.4%	0.056%
11/13/2024	FMR LLC	4,950,224	$249.59M	0.0%	+35.8%	7.749%
11/13/2024	The Manufacturers Life Insurance Company	118,126	$5.96M	0.0%	+3.4%	0.185%
11/12/2024	Westfield Capital Management Co. LP	1,167,358	$58.86M	0.3%	+4.4%	1.827%
11/5/2024	Victory Capital Management Inc.	217,839	$10.98M	0.0%	+24.7%	0.341%
11/5/2024	GSA Capital Partners LLP	22,127	$1.12M	0.1%	+1.9%	0.035%
10/30/2024	AlphaCentric Advisors LLC	14,000	$0.71M	0.5%	N/A	0.022%
10/29/2024	Harbor Capital Advisors Inc.	77,468	$3.91M	0.2%	+100.2%	0.121%
10/28/2024	Rice Hall James & Associates LLC	75,469	$3.81M	0.2%	N/A	0.118%
10/28/2024	US Bancorp DE	869	$44K	0.0%	N/A	0.001%
10/28/2024	Congress Asset Management Co.	66,641	$3.36M	0.0%	N/A	0.104%
10/5/2024	Handelsbanken Fonder AB	13,000	$0.66M	0.0%	+26.2%	0.020%
8/16/2024	Quarry LP	3,000	$0.13M	0.0%	+172.7%	0.005%
8/15/2024	The Manufacturers Life Insurance Company	114,234	$5.02M	0.0%	+37.9%	0.179%
8/15/2024	Millennium Management LLC	216,964	$9.54M	0.0%	+596.0%	0.340%
8/14/2024	Fred Alger Management LLC	659,029	$28.98M	0.1%	-1.2%	1.032%
8/14/2024	Marshall Wace LLP	1,098,630	$48.31M	0.1%	+115.0%	1.720%
8/14/2024	Logos Global Management LP	750,000	$32.98M	2.6%	N/A	1.174%
8/14/2024	Integral Health Asset Management LLC	220,000	$9.67M	0.9%	-47.6%	0.344%
8/14/2024	Avoro Capital Advisors LLC	2,770,000	$121.80M	1.6%	+7.4%	4.336%
8/14/2024	HighVista Strategies LLC	42,249	$1.86M	0.7%	-29.3%	0.066%
8/8/2024	Federated Hermes Inc.	1,128,428	$49.62M	0.1%	+2.6%	1.766%
8/5/2024	Victory Capital Management Inc.	174,682	$7.68M	0.0%	+16.0%	0.273%
8/3/2024	TD Asset Management Inc	209,234	$9.20M	0.0%	+2.5%	0.327%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	2,753	$0.12M	0.0%	-31.7%	0.004%
7/9/2024	Harbor Capital Advisors Inc.	38,689	$1.70M	0.1%	+371.4%	0.061%
7/5/2024	DNB Asset Management AS	7,372	$0.32M	0.0%	+29.8%	0.012%
5/16/2024	California State Teachers Retirement System	16,366	$0.82M	0.0%	+2.7%	0.026%
5/16/2024	Kennedy Capital Management LLC	26,713	$1.34M	0.0%	-24.4%	0.042%
5/15/2024	Bellevue Group AG	4,400	$0.22M	0.0%	N/A	0.007%
5/15/2024	Price T Rowe Associates Inc. MD	2,135,883	$107.29M	0.0%	-7.7%	3.343%
5/15/2024	Affinity Asset Advisors LLC	75,000	$3.77M	0.5%	+5.7%	0.117%
5/14/2024	EntryPoint Capital LLC	862	$43K	0.0%	-49.9%	0.001%
5/14/2024	StemPoint Capital LP	90,647	$4.55M	1.2%	-45.8%	0.142%
5/14/2024	Decheng Capital LLC	166,600	$8.37M	1.1%	N/A	0.261%
5/13/2024	Clearbridge Investments LLC	28,551	$1.43M	0.0%	N/A	0.045%
5/10/2024	Vanguard Group Inc.	92,298	$4.64M	0.0%	+25.3%	0.144%
5/10/2024	Westfield Capital Management Co. LP	910,873	$45.75M	0.2%	+48.8%	1.426%
5/9/2024	Lord Abbett & CO. LLC	86,487	$4.34M	0.0%	-45.7%	0.135%
5/8/2024	Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.	229,230	$11.51M	1.8%	+0.1%	0.359%
5/7/2024	TimesSquare Capital Management LLC	209,487	$10.52M	0.2%	-57.1%	0.328%
5/7/2024	SG Americas Securities LLC	14,458	$0.73M	0.0%	N/A	0.023%
3/22/2024	PNC Financial Services Group Inc.	6,147	$0.37M	0.0%	+50.7%	0.010%
3/5/2024	Wellington Management Group LLP	257,192	$15.53M	0.0%	-39.3%	0.412%
2/26/2024	Perceptive Advisors LLC	82,398	$4.98M	0.1%	N/A	0.132%
2/20/2024	Quarry LP	850	$51K	0.0%	N/A	0.001%
2/16/2024	Price T Rowe Associates Inc. MD	2,314,012	$139.74M	0.0%	+9.3%	3.705%
2/15/2024	Parkman Healthcare Partners LLC	82,009	$4.95M	0.7%	+53.9%	0.131%
2/14/2024	Avoro Capital Advisors LLC	2,580,000	$155.81M	2.2%	+29.0%	4.131%
2/14/2024	Lighthouse Investment Partners LLC	18,728	$1.13M	0.1%	N/A	0.030%
2/14/2024	Sectoral Asset Management Inc.	30,005	$1.81M	0.8%	-69.4%	0.048%
2/14/2024	CenterBook Partners LP	22,781	$1.38M	0.2%	+99.5%	0.036%
2/13/2024	Affinity Asset Advisors LLC	70,988	$4.29M	0.8%	+42.0%	0.114%
2/13/2024	Finepoint Capital LP	895,000	$54.05M	15.4%	+170.1%	1.433%
2/12/2024	TD Asset Management Inc	209,142	$12.63M	0.0%	+4.4%	0.335%
2/9/2024	Westfield Capital Management Co. LP	612,050	$36.96M	0.2%	+56.4%	0.980%
2/9/2024	PNC Financial Services Group Inc.	6,147	$0.37M	0.0%	+50.7%	0.010%
2/7/2024	Teacher Retirement System of Texas	4,149	$0.25M	0.0%	-19.3%	0.007%
2/7/2024	TimesSquare Capital Management LLC	488,805	$29.52M	0.4%	+18.9%	0.783%
2/6/2024	Swiss National Bank	35,300	$2.13M	0.0%	-11.3%	0.057%
2/5/2024	Victory Capital Management Inc.	154,607	$9.34M	0.0%	-15.5%	0.248%
1/31/2024	Federated Hermes Inc.	1,060,526	$64.05M	0.2%	-2.2%	1.698%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	3,589	$0.22M	0.0%	N/A	0.006%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	18,699	$1.13M	0.0%	+48.6%	0.030%
1/24/2024	Stratos Wealth Partners LTD.	3,350	$0.20M	0.0%	N/A	0.005%
12/1/2023	Wellington Management Group LLP	423,387	$24.13M	0.0%	+2.4%	0.678%
11/22/2023	Polar Capital Holdings Plc	939,012	$53.52M	0.4%	-41.9%	1.504%
11/22/2023	Graham Capital Management L.P.	4,352	$0.25M	0.0%	N/A	0.007%
11/21/2023	Walleye Capital LLC	67,926	$3.87M	0.0%	N/A	0.109%
11/17/2023	TimesSquare Capital Management LLC	411,215	$23.44M	0.4%	+1,270.7%	0.658%
11/15/2023	Sectoral Asset Management Inc.	97,965	$5.58M	1.1%	-46.9%	0.157%
11/15/2023	Adage Capital Partners GP L.L.C.	1,952,703	$111.30M	0.3%	+42.3%	3.127%
11/15/2023	Affinity Asset Advisors LLC	50,000	$2.85M	0.8%	N/A	0.080%
11/14/2023	MPM Bioimpact LLC	294,190	$16.77M	4.5%	-0.3%	0.471%
11/14/2023	Schonfeld Strategic Advisors LLC	340,700	$19.42M	0.2%	+188.8%	0.546%
11/14/2023	Fred Alger Management LLC	832,951	$47.48M	0.3%	+11.4%	1.334%
11/14/2023	Soros Fund Management LLC	56,000	$3.19M	0.0%	N/A	0.090%
11/14/2023	Avidity Partners Management LP	777,172	$44.30M	1.8%	+94.3%	1.244%
11/14/2023	Westfield Capital Management Co. LP	391,279	$22.30M	0.2%	-4.6%	0.627%
11/13/2023	CHI Advisors LLC	60,000	$3.42M	1.0%	N/A	0.096%
11/13/2023	Federated Hermes Inc.	1,084,250	$61.80M	0.2%	-7.3%	1.736%
11/13/2023	CenterBook Partners LP	11,421	$0.65M	0.1%	N/A	0.018%
11/13/2023	Invesco Ltd.	250,233	$14.26M	0.0%	-4.4%	0.401%
11/13/2023	FMR LLC	3,397,253	$193.64M	0.0%	+0.6%	5.440%
11/13/2023	Atika Capital Management LLC	85,000	$4.85M	0.6%	N/A	0.136%
11/13/2023	Lord Abbett & CO. LLC	176,037	$10.03M	0.0%	-9.6%	0.282%
11/13/2023	DekaBank Deutsche Girozentrale	6,200	$0.35M	0.0%	N/A	0.010%
11/13/2023	Maven Securities LTD	10,000	$0.57M	0.0%	N/A	0.016%
11/8/2023	Swiss National Bank	39,800	$2.27M	0.0%	N/A	0.064%
11/8/2023	J.P. Morgan Private Wealth Advisors LLC	4,310	$0.25M	0.0%	N/A	0.007%

Data available starting January 2016

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.

Today's Range

Now: $54.32

$51.43

$54.93

50 Day Range

MA: $50.11

$46.20

$55.40

52 Week Range

Now: $54.32

$37.55

$64.98

Volume

223,381 shs

Average Volume

243,286 shs

Market Capitalization

$3.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of MoonLake Immunotherapeutics?: MoonLake Immunotherapeutics' top insider shareholders include:
Bihua Chen (Major Shareholder)
Da Silva Jorge Santos (CEO)
Matthias Bodenstedt (CFO)
Simon Sturge (Director)
Kristian Reich (Insider)
Learn More about top insider investors at MoonLake Immunotherapeutics.
Who are the major institutional investors of MoonLake Immunotherapeutics?: MoonLake Immunotherapeutics' top institutional shareholders include:
FMR LLC — 7.75%
Holocene Advisors LP — 2.48%
Westfield Capital Management Co. LP — 1.83%
Fred Alger Management LLC — 1.04%
Victory Capital Management Inc. — 0.34%
Wellington Management Group LLP — 0.30%
Learn More about top institutional investors of MoonLake Immunotherapeutics stock.
Which institutional investors are selling MoonLake Immunotherapeutics stock?: In the previous quarter, MLTX stock was sold by these institutional investors:
Wellington Management Group LLP
Holocene Advisors LP
Jane Street Group LLC
Belvedere Trading LLC
In the previous year, company insiders that have sold MoonLake Immunotherapeutics company stock include:
Bihua Chen (Major Shareholder)
Da Silva Jorge Santos (CEO)
Matthias Bodenstedt (CFO)
Simon Sturge (Director)
Learn More investors selling MoonLake Immunotherapeutics stock.
Which institutional investors are buying MoonLake Immunotherapeutics stock?: In the previous quarter, MLTX stock was bought by institutional investors including:
FMR LLC
Rice Hall James & Associates LLC
Congress Asset Management Co.
Westfield Capital Management Co. LP
Victory Capital Management Inc.
State Street Corp
Harbor Capital Advisors Inc.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC